(a) Structure of a triphosphate bound Rho GTPase displaying the exposed, Rho GTPase specific insert helix. (b) Sequence alignment of selected human Rho, Ras, Rab, Ran, and Arf GTPase families. The insert helix 4 is a specific feature of Rho GTPases. The secondary structure of Cdc42 as determine here is displayed above the sequence. The canonical Gdomain elements G1 to G5 and the hypervariable region at the C-terminus mediating membrane binding are indicated (a) Pull downs using GST-fusion proteins as indicated show that the Rac1-L61 triple mutant but not Cdc42-L61 retains its ability to interact with the WAVE complex, as exemplified by anti-Sra-1 Western Blotting. In contrast, and opposite to Cdc42-L61, the triple mutant lacks interaction with the bona fide Cdc42 effector N-WASP, as expected. This confirms that the gain of effector interaction of the Rac1-L61 triple mutant is restricted to FMNL proteins. GST alone was used as a control. (b) Superimposition of the Cdc42-WASP complex structure (1CEE, ref.
3) with the Cdc42-FMNL2 structure determined here. The three key determining residues E95, K131, and N132 (colored blue) that led to a gain-of-function mutation for Fig. 7 ). The area corresponding to the lamella and the total cell area were digitally drawn as depicted in the scheme and with the help of phase contrast images of live cells acquired in parallel to widefield fluorescence images (see also Methods). These regions were subsequently copied onto corresponding fluorescent images, and average fluorescence intensities computed using Metamorph software. Analysis of the association of FMNL2 N binding to phosphoinositolphosphates using a PIP strip assay. FMNL2 predominantly associates to negatively charged lipids whereas the non-charged lipids PC, PE and LPC are not bound. Overall, the PIP strip screen suggests that FMNL2 N has no preference for a specific inositol phosphate head group but rather associates to negatively charged lipids in general. C-terminally His-tagged FMNL2 was detected by an anti-His antibody. B16-F1 cells transiently expressing FMNL2-EGFP (left panels) were fixed and counterstained for the actin cytoskeleton using phalloidin (middle panels). Right panels show magnified insets (merge) boxed in overview images on middle and left panels. FMNL2 and actin filaments in merged panels are displayed in green and red, respectively. Note the accumulation of FMNL2 at the tips of filopodia and lamellipodia.
